{"denoms":[{"counts":[{"groupId":"BG000","value":"33"}],"units":"Participants"}],"groups":[{"description":"Cetuximab- 250 mg/m2 on Day 1 after the first dose of radiation was administered to all patients. Hydroxyurea - 500 mg orally every 12 hours with the morning dose administered 2 hours before radiation. Fluorouracil - continuous-infusion 5-FU at a dose of 600 mg/m2 daily for 120 hours. Radiotherapy.","id":"BG000","title":"Advanced Head and Neck Cancer"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"18","upperLimit":"77","value":"59"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"24"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"23"}]}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"Black"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"Hispanic"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"Asian"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"19"}]}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"2"}],"description":"The Eastern Cooperative Oncology Group (ECOG)\n\n0 - Fully active, able to carry on all pre-disease performance without restriction\n\n1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2- Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours","paramType":"NUMBER","title":"Performance score","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"27"}]}],"title":"0-1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"≥2"}],"description":"The Charlson Comorbidity Index contains 19 categories of comorbidity and predicts the ten-year mortality for a patient who may have a range of co-morbid conditions. Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with each one. Scores are summed to provide a total score to predict mortality. Higher scores indicating greater comorbidity (patients with a score \\> 5 have essentially a 100% risk of dying at one year).","paramType":"NUMBER","title":"Charlson comorbidity score","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"title":"None"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}]}],"title":"Occasional"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Moderate"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"Heavy"}],"paramType":"NUMBER","title":"Alcohol consumption","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"None"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Cigar, pipe, or betel nut only"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}]}],"title":"≤20 pack-y"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"20.1-40 packk-y"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"title":">40 pack-y"}],"paramType":"NUMBER","title":"Smoking","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Sinonasal"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Nasopharynx"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}]}],"title":"Oropharynx"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"Oral cavity"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Salivary gland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Larynx"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Hyopharynx"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Unknown primary"}],"paramType":"NUMBER","title":"Primary site","unitOfMeasure":"participants"}]}